FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of $0.06, $0.14 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $172.1 million versus the consensus estimate of $143.63 million.
GUIDANCE:
Tandem Diabetes sees FY2021 revenue of $670-685 million, versus the consensus... More

